Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II studyS Kakolyris, D Mavroudis, N Tsavaris, et al.
British Journal of Cancer|March 20, 2014
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancerI Balgkouranidou, M Chimonidou, G Milaki, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2010
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancerN Xenidis, K Neanidis, K Amarantidis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trialJ Souglakos, N Vardakis, N Androulakis, et al.
Digestive Diseases (Basel, Switzerland)|March 27, 2007
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trialJ Souglakos, N Vardakis, N Androulakis, et al.
Oncology Research|May 5, 2007
A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumorsK Amarantidis, K Houhouli, K Papatheodorou, et al.
American Journal of Clinical Oncology|December 22, 1999
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatinS Kakolyris, C Kourousis, M Koukourakis, et al.
American Journal of Clinical Oncology|October 22, 1998
Treatment of non-small-cell lung cancer with prolonged oral etoposideS Kakolyris, G Samonis, M Koukourakis, et al.
Critical Reviews in Oncology/Hematology|September 5, 2009
Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)L Vamvakas, A Athanasiadis, A Karampeazis, et al.
Oncology|December 2, 2005
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trialJ Souglakos, A Pallis, S Kakolyris, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II studyS Kakolyris, D Mavroudis, N Tsavaris, et al.
British Journal of Cancer|March 20, 2014
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancerI Balgkouranidou, M Chimonidou, G Milaki, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2010
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancerN Xenidis, K Neanidis, K Amarantidis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trialJ Souglakos, N Vardakis, N Androulakis, et al.
Digestive Diseases (Basel, Switzerland)|March 27, 2007
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trialJ Souglakos, N Vardakis, N Androulakis, et al.
Oncology Research|May 5, 2007
A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumorsK Amarantidis, K Houhouli, K Papatheodorou, et al.
American Journal of Clinical Oncology|December 22, 1999
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatinS Kakolyris, C Kourousis, M Koukourakis, et al.
American Journal of Clinical Oncology|October 22, 1998
Treatment of non-small-cell lung cancer with prolonged oral etoposideS Kakolyris, G Samonis, M Koukourakis, et al.
Critical Reviews in Oncology/Hematology|September 5, 2009
Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)L Vamvakas, A Athanasiadis, A Karampeazis, et al.
Oncology|December 2, 2005
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trialJ Souglakos, A Pallis, S Kakolyris, et al.
Pageof 13